A recent nationwide study from Japan, published this week in BMC Public Health, reveals a statistically significant association between antibiotic employ before and during pregnancy and increased psychological distress in expectant mothers. The research, analyzing data from nearly 95,000 pregnant women, suggests a dose-response relationship, with greater antibiotic exposure correlating with higher rates of moderate to severe psychological distress. This finding underscores the complex interplay between the microbiome, immune function, and mental health during a critical developmental period.
Perinatal mental health challenges, including depression and anxiety, represent a substantial public health concern globally. These conditions not only impact maternal well-being but as well have documented adverse effects on fetal development and long-term child health outcomes. Identifying modifiable risk factors, such as antibiotic exposure, is crucial for preventative interventions and improved maternal care.
In Plain English: The Clinical Takeaway
- Antibiotics & Mood: Using antibiotics before or during pregnancy *may* slightly increase the risk of feeling anxious or depressed.
- Not a Ban, But Awareness: This doesn’t mean you should avoid antibiotics when sick. It means discussing antibiotic use with your doctor is important, especially when planning a pregnancy or already pregnant.
- Gut Health Connection: Antibiotics can disrupt the natural balance of bacteria in your gut, and this disruption may play a role in affecting your mood.
The Gut-Brain Axis and Perinatal Mental Health
The study’s findings align with growing evidence highlighting the critical role of the gut microbiota – the trillions of microorganisms residing in the digestive tract – in modulating brain function and mental health. This bidirectional communication pathway, known as the gut-brain axis, involves complex interactions between the gut microbiome, the immune system, the endocrine system (hormones), and the central nervous system. Antibiotics, while essential for treating bacterial infections, are known to disrupt the composition and diversity of the gut microbiome, potentially leading to dysbiosis – an imbalance in the microbial community.
Dysbiosis has been implicated in a range of neuropsychiatric disorders, including depression, anxiety, and autism spectrum disorder. Specifically, alterations in gut microbial metabolites, such as short-chain fatty acids (SCFAs) – produced by bacterial fermentation of dietary fiber – can influence neurotransmitter synthesis, neuroinflammation, and brain plasticity. The precise mechanism by which antibiotic-induced dysbiosis contributes to psychological distress during pregnancy remains under investigation, but it likely involves a combination of these factors. Further research is needed to determine if restoring gut microbial balance through interventions like probiotics or dietary modifications can mitigate these effects. (Cryan JF, et al. The Microbiome-Gut-Brain Axis. Physiological Reviews. 2019. 99(2):801-854.)
Geographical Impact and Regulatory Considerations
The observed association between antibiotic use and psychological distress has implications for healthcare systems worldwide. In the United States, the Centers for Disease Control and Prevention (CDC) has been actively promoting antibiotic stewardship programs to combat the growing threat of antibiotic resistance. These programs aim to optimize antibiotic prescribing practices, reducing unnecessary use and minimizing the selective pressure driving the evolution of resistant bacteria. Although, the potential impact of antibiotic use on maternal mental health has not been fully integrated into these stewardship efforts.
Similarly, the European Medicines Agency (EMA) and the National Health Service (NHS) in the United Kingdom are implementing strategies to address antibiotic resistance. The findings from the Japanese study could inform the development of more comprehensive guidelines for antibiotic prescribing during pregnancy, emphasizing the importance of a careful risk-benefit assessment and consideration of alternative treatment options when appropriate. The World Health Organization (WHO) has also identified antibiotic resistance as a major global health threat, advocating for coordinated international action to preserve the effectiveness of these life-saving medications.
“We are increasingly recognizing the profound impact of the microbiome on overall health, including mental well-being. This study adds to the growing body of evidence suggesting that disruptions to the gut microbiome, even from seemingly benign interventions like antibiotic use, can have far-reaching consequences, particularly during vulnerable periods like pregnancy.” – Dr. Rob Knight, Professor of Pediatrics and Computer Science & Engineering, University of California San Diego, and Director of the Center for Microbiome Innovation.
Funding and Bias Transparency
The research was primarily funded by the Japan Environment and Children’s Study (JECS), a large-scale, nationwide birth cohort study supported by the Ministry of the Environment and the Ministry of Health, Labour and Welfare in Japan. While the JECS receives funding from various sources, including government agencies and private foundations, the researchers have declared no competing interests. This funding structure is generally considered to minimize potential bias, as the study’s objectives are aligned with public health goals rather than commercial interests.
Data Summary: Antibiotic Exposure and Psychological Distress
| Antibiotic Exposure | Moderate Psychological Distress (K6 ≥ 5) – Adjusted Odds Ratio (95% CI) | Severe Psychological Distress (K6 > 13) – Adjusted Odds Ratio (95% CI) |
|---|---|---|
| No Antibiotic Use (Reference) | 1.00 | 1.00 |
| Antibiotic Use During Either Period | 1.12 (1.06 – 1.18) | 1.07 (0.99 – 1.15) |
| Antibiotic Use During Both Periods | 1.22 (1.15 – 1.29) | 1.50 (1.31 – 1.72) |
Contraindications & When to Consult a Doctor
It is crucial to emphasize that this study does *not* advocate for avoiding antibiotics when medically indicated. Antibiotics remain essential for treating bacterial infections, and delaying or withholding appropriate treatment can have serious consequences. However, pregnant women and those planning a pregnancy should discuss the potential risks and benefits of antibiotic use with their healthcare provider.
Consult a doctor immediately if you experience any of the following:
- Persistent feelings of sadness, hopelessness, or anxiety.
- Difficulty sleeping or changes in appetite.
- Loss of interest in activities you once enjoyed.
- Thoughts of harming yourself or your baby.
Individuals with a history of mental health conditions, particularly depression or anxiety, may be at increased risk and should be closely monitored during and after antibiotic treatment. Women with pre-existing gut dysbiosis or a family history of autoimmune disorders may also be more susceptible to the psychological effects of antibiotic exposure.
Looking Ahead: Longitudinal Studies and Targeted Interventions
The findings from this study highlight the need for further research to elucidate the complex relationship between antibiotic use, the gut microbiome, and maternal mental health. Longitudinal studies, following women from preconception through pregnancy and postpartum, are essential to determine the temporal sequence of events and establish causality. Investigating the efficacy of targeted interventions, such as probiotic supplementation or dietary modifications, to restore gut microbial balance and mitigate psychological distress is also a priority. A holistic approach to maternal care, integrating considerations of both physical and mental health, is crucial for optimizing outcomes for mothers and their children.
“This research underscores the importance of precision medicine in pregnancy. We need to move beyond a one-size-fits-all approach to antibiotic prescribing and tailor treatment decisions to individual patient risk factors and microbiome profiles.” – Dr. Elena Ramirez, Epidemiologist, CDC Division of Reproductive Health.
References
- Matsumura, K., et al. (2026). Periconceptional antibiotic use and early- to mid-pregnancy psychological distress in a nationwide birth cohort: cross-sectional analysis from the Japan Environment and Children’s Study. BMC Public Health. DOI: 10.1186/s12889-025-26119-0.
- Cryan JF, O’Mahony SM, Hyland NP, et al. The Microbiome-Gut-Brain Axis. Physiological Reviews. 2019;99(2):801-854. https://pubmed.ncbi.nlm.nih.gov/32698663/
- CDC. Antibiotic Stewardship. https://www.cdc.gov/antibiotic-use/index.html
- European Medicines Agency. Antibiotics. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/antibiotic-resistance
- World Health Organization. Antibiotic Resistance. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance
Disclaimer: This article provides general medical information and should not be considered a substitute for professional medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment.
